Literature DB >> 16793284

Overproduction, purification, and biochemical characterization of the dual specificity H1 protein phosphatase encoded by variola major virus.

Joseph E Tropea1, Jason Phan, David S Waugh.   

Abstract

Smallpox, a highly contagious infectious disease caused by the variola major virus, has an overall mortality rate of about 30%. Because there currently is no specific treatment for smallpox, and the only prevention is vaccination, there is an urgent need for the development of effective antiviral drugs. The dual specificity protein phosphatase encoded by the smallpox virus (H1) is essential for the production of infectious viral particles, making it a promising molecular target for antiviral therapeutics. Here, we report the molecular cloning, overproduction, purification, and initial biochemical characterization of H1 phosphatase, thereby paving the way for the discovery of small molecule inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793284     DOI: 10.1016/j.pep.2006.05.007

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  9 in total

1.  Targeting Protein-Protein Interactions of Tyrosine Phosphatases with Microarrayed Fragment Libraries Displayed on Phosphopeptide Substrate Scaffolds.

Authors:  Megan Hogan; Medhanit Bahta; Kohei Tsuji; Trung X Nguyen; Scott Cherry; George T Lountos; Joseph E Tropea; Bryan M Zhao; Xue Zhi Zhao; David S Waugh; Terrence R Burke; Robert G Ulrich
Journal:  ACS Comb Sci       Date:  2019-01-31       Impact factor: 3.784

2.  Oxime-based click chemistry in the development of 3-isoxazolecarboxylic acid containing inhibitors of Yersinia pestis protein tyrosine phosphatase, YopH.

Authors:  Medhanit Bahta; Terrence R Burke
Journal:  ChemMedChem       Date:  2011-06-10       Impact factor: 3.466

3.  Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.

Authors:  Medhanit Bahta; George T Lountos; Beverly Dyas; Sung-Eun Kim; Robert G Ulrich; David S Waugh; Terrence R Burke
Journal:  J Med Chem       Date:  2011-03-28       Impact factor: 7.446

4.  Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons.

Authors:  Brandon A Mann; Julia He Huang; Ping Li; Hua-Chen Chang; Roger B Slee; Audrey O'Sullivan; Mathur Anita; Norman Yeh; Michael J Klemsz; Randy R Brutkiewicz; Janice S Blum; Mark H Kaplan
Journal:  J Interferon Cytokine Res       Date:  2008-06       Impact factor: 2.607

5.  The ability to enhance the solubility of its fusion partners is an intrinsic property of maltose-binding protein but their folding is either spontaneous or chaperone-mediated.

Authors:  Sreejith Raran-Kurussi; David S Waugh
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

Review 6.  Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.

Authors:  Yuchen Nan; Chunyan Wu; Yan-Jin Zhang
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

7.  Purification of Bionanoparticles.

Authors:  L Pedro; S S Soares; G N M Ferreira
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

8.  Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases.

Authors:  Bryan M Zhao; Sarah L Keasey; Joseph E Tropea; George T Lountos; Beverly K Dyas; Scott Cherry; Sreejith Raran-Kurussi; David S Waugh; Robert G Ulrich
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

Review 9.  Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.

Authors:  Stephen B Fleming
Journal:  Vaccines (Basel)       Date:  2016-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.